Status:
COMPLETED
Atomization Vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation
Lead Sponsor:
Zagazig University
Conditions:
Awake Fiberoptic Intubation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Intubation of difficult airway is a challenge for anesthetist. There many causes of difficult airway, and previous studies concluded that awake fiber-optic intubation (AFOI) is the gold standard for t...
Detailed Description
Site of the Study: Zagazig university surgical hospitals. Type of the Study: Prospective randomized double-blinded clinical trial. Withdrawal Criteria: The patient has the right to withdraw from th...
Eligibility Criteria
Inclusion
- Consent obtained from all patients included in this study.
- Age 18 - 60 years, of both sexes.
- ASA class I, II and III.
- Anticipated difficult airway; SARI score ≥ 4, airway pathology, craniofacial abnormalities, or cervical spine instability.
- Scheduled for elective non-cardiac surgery requiring general anesthesia and endotracheal intubation.
Exclusion
- Patient refusal, uncooperative and mentally retarded patients.
- Full stomach patients.
- Patients with nasal fractures or trauma, fracture base of the skull, bleeding disorder, epistaxis or active oral bleeding.
- Active cough or respiratory tract infection and bronchial asthma.
- Allergy to lidocaine.
- Raised intracranial pressure or intraocular pressure.
- Cerebral aneurysm, history of recent acute myocardial infarction or cerebrovascular accident.
Key Trial Info
Start Date :
February 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05320731
Start Date
February 20 2022
End Date
August 15 2024
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig university hospitals
Zagazig, Sharqia Province, Egypt, 44111